OGEN vs TMO · rev $37.7K vs P/E 24, rev $44.56B
Oragenics Inc (OGEN) versus Thermo Fisher Scientific Inc (TMO) — a side-by-side from cached financials, not a winner call.
Oragenics Inc (OGEN) is a biotechnology company listed on US.
Thermo Fisher Scientific Inc (TMO) is a diagnostics & research company listed on US.
Latest reported OGEN revenue for 2023-12-31 was $37.7K. Net income was -$20.7M. Revenue was down 71.4% from 2022-12-31 to 2023-12-31. OGEN currently screens at market cap $2.7M.
Latest reported TMO revenue for 2025-12-31 was $44.56B. Net income was $6.70B. Revenue was up 3.9% from 2024-12-31 to 2025-12-31. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
OGEN currently screens at market cap $2.7M. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
Not investment advice. Open the OGEN and TMO stock pages for the full models.
Not investment advice.